Drug Distribution: Volume of Distribution

Volume of distribution is the theoretical fluid volume required to contain an entire drug at the same concentration as observed in plasma. It represents how extensively a drug distributes throughout body compartments. This concept helps determine appropriate dosing strategies and predict drug behavior in the body.

The intracellular fluid compartment comprises two-thirds of total body water, while the extracellular fluid compartment—comprising plasma and interstitial fluid—accounts for one-third. Drugs distribute differently based on their ability to cross compartment barriers, directly influencing their volume of distribution and therapeutic effectiveness.

High-molecular-weight or plasma-protein-bound drugs cannot pass through capillary slit junctions, so they accumulate in the plasma and exhibit low volume of distribution. Since these drugs remain confined to the vascular space, they have limited access to tissue compartments and require lower loading doses.

Low-molecular-weight lipophilic drugs can cross capillary slit junctions and easily penetrate cell lipid membranes, accumulating in intracellular space and exhibiting high volume of distribution. These drugs remain in extraplasmic space longer, making them inaccessible to elimination organs and requiring higher loading doses to achieve desired plasma concentrations.

Low-molecular-weight hydrophilic drugs cross capillary slit junctions but cannot penetrate cell lipid membranes, accumulating in extracellular space with intermediate volume of distribution. In contrast, lipophilic drugs penetrate both barriers and distribute extensively into intracellular compartments, resulting in higher volume of distribution and prolonged drug action.

Drugs with high volume of distribution escape plasma rapidly and remain in extraplasmic space, requiring higher loading doses to achieve desired plasma concentrations. Conversely, drugs with low volume of distribution remain longer in plasma, necessitating lower doses to reach therapeutic levels without exceeding safe concentrations.

Drugs with high volume of distribution remain in extraplasmic space longer, making them inaccessible to elimination organs and extending their duration of action. This prolonged presence in body tissues results from their ability to escape plasma and accumulate in intracellular and interstitial compartments, delaying clearance.